Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]RM2 PET/CT in Primary Prostate Cancer
NCT02483884Phase 2Terminated
- Sponsor
- Life Molecular Imaging
- Start
- May 2015
- Primary completion
- Dec 2016
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of 68Ga-DOTA-Bombesin in prostate cancer (PCa), sponsored by Life Molecular Imaging. Started May 2015; status: terminated.
02
Drugs
68Ga-DOTA-Bombesin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02483884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02483884.